Core Viewpoint - The announcement details the expected daily related transactions for the year 2026 by Ningbo SANSING Medical Electric Co., Ltd, indicating that these transactions are necessary for the company's operations and will not adversely affect its independence or financial health [2][14]. Group 1: Daily Related Transactions Overview - The daily related transactions for 2026 do not require shareholder meeting approval [2]. - The expected amount for daily related transactions in 2026 is capped at 220 million yuan [5]. - The board of directors approved the proposal for these transactions during a meeting held on December 30, 2025, with related directors abstaining from voting [3][17]. Group 2: Related Parties and Relationships - The main related party is AUX Group Co., Ltd, which is the controlling shareholder of the company [5][6]. - Other related parties include Ningbo SANSING Technology Co., Ltd and Ningbo AUX Kaiyun Medical Investment Partnership, which are also linked to the company's operations [8][9]. - The financial health of these related parties is stable, indicating a good capacity to fulfill their obligations [12]. Group 3: Transaction Details and Pricing Policy - The daily related transactions include procurement and sales of goods, property services, medical services, and leasing of facilities [12]. - Pricing for these transactions is based on fair market value, ensuring fairness and transparency [13]. Group 4: Impact on the Company - The transactions are aimed at optimizing resource allocation and improving operational efficiency without compromising the company's independence [14]. - The company asserts that these transactions will not negatively impact its financial status or operational results, nor will they harm the interests of minority shareholders [14].
宁波三星医疗电气股份有限公司关于2026年度预计日常关联交易的公告